Global Onychomycosis Treatment Market Growth (Status and Outlook) 2025-2031
According to this study, the global Onychomycosis Treatment market size will reach US$ 4375 million by 2031.
Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails. Complications may include cellulitis of the lower leg. A number of different types of fungus can cause onychomycosis, including dermatophytes and Fusarium. Risk factors include athlete's foot, other nail diseases, exposure to someone with the condition, peripheral vascular disease, and poor immune function. The diagnosis is generally suspected based on the appearance and confirmed by laboratory testing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Onychomycosis Treatment Industry Forecast” looks at past sales and reviews total world Onychomycosis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Onychomycosis Treatment sales for 2025 through 2031. With Onychomycosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Onychomycosis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Onychomycosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Onychomycosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Onychomycosis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Onychomycosis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Onychomycosis Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Onychomycosis Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails. Complications may include cellulitis of the lower leg. A number of different types of fungus can cause onychomycosis, including dermatophytes and Fusarium. Risk factors include athlete's foot, other nail diseases, exposure to someone with the condition, peripheral vascular disease, and poor immune function. The diagnosis is generally suspected based on the appearance and confirmed by laboratory testing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Onychomycosis Treatment Industry Forecast” looks at past sales and reviews total world Onychomycosis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Onychomycosis Treatment sales for 2025 through 2031. With Onychomycosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Onychomycosis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Onychomycosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Onychomycosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Onychomycosis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Onychomycosis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Onychomycosis Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Onychomycosis Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oral Medicine
- External Medicine
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- GSK
- Novartis
- Pfizer
- Bausch Health
- Kaken Pharmaceutical
- Galderma
- Bayer
- Lumenis
- Moberg Pharma
- Cipla
- Biofrontera
- Leo Pharma
- Dr. Reddy's Laboratories
- Medimetriks Pharmaceuticals
- Xiuzheng Pharmaceutical
- Letai
- Qilu Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Onychomycosis Treatment Market Size (2020-2031)
2.1.2 Onychomycosis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Onychomycosis Treatment by Country/Region (2020, 2024 & 2031)
2.2 Onychomycosis Treatment Segment by Type
2.2.1 Oral Medicine
2.2.2 External Medicine
2.3 Onychomycosis Treatment Market Size by Type
2.3.1 Onychomycosis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
2.4 Onychomycosis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Onychomycosis Treatment Market Size by Application
2.5.1 Onychomycosis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
3 ONYCHOMYCOSIS TREATMENT MARKET SIZE BY PLAYER
3.1 Onychomycosis Treatment Market Size Market Share by Player
3.1.1 Global Onychomycosis Treatment Revenue by Player (2020-2025)
3.1.2 Global Onychomycosis Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Onychomycosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS TREATMENT BY REGION
4.1 Onychomycosis Treatment Market Size by Region (2020-2025)
4.2 Global Onychomycosis Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Onychomycosis Treatment Market Size Growth (2020-2025)
4.4 APAC Onychomycosis Treatment Market Size Growth (2020-2025)
4.5 Europe Onychomycosis Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Onychomycosis Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Onychomycosis Treatment Market Size by Country (2020-2025)
5.2 Americas Onychomycosis Treatment Market Size by Type (2020-2025)
5.3 Americas Onychomycosis Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Onychomycosis Treatment Market Size by Region (2020-2025)
6.2 APAC Onychomycosis Treatment Market Size by Type (2020-2025)
6.3 APAC Onychomycosis Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Onychomycosis Treatment Market Size by Country (2020-2025)
7.2 Europe Onychomycosis Treatment Market Size by Type (2020-2025)
7.3 Europe Onychomycosis Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Onychomycosis Treatment by Region (2020-2025)
8.2 Middle East & Africa Onychomycosis Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Onychomycosis Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONYCHOMYCOSIS TREATMENT MARKET FORECAST
10.1 Global Onychomycosis Treatment Forecast by Region (2026-2031)
10.1.1 Global Onychomycosis Treatment Forecast by Region (2026-2031)
10.1.2 Americas Onychomycosis Treatment Forecast
10.1.3 APAC Onychomycosis Treatment Forecast
10.1.4 Europe Onychomycosis Treatment Forecast
10.1.5 Middle East & Africa Onychomycosis Treatment Forecast
10.2 Americas Onychomycosis Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Onychomycosis Treatment Forecast
10.2.2 Canada Market Onychomycosis Treatment Forecast
10.2.3 Mexico Market Onychomycosis Treatment Forecast
10.2.4 Brazil Market Onychomycosis Treatment Forecast
10.3 APAC Onychomycosis Treatment Forecast by Region (2026-2031)
10.3.1 China Onychomycosis Treatment Market Forecast
10.3.2 Japan Market Onychomycosis Treatment Forecast
10.3.3 Korea Market Onychomycosis Treatment Forecast
10.3.4 Southeast Asia Market Onychomycosis Treatment Forecast
10.3.5 India Market Onychomycosis Treatment Forecast
10.3.6 Australia Market Onychomycosis Treatment Forecast
10.4 Europe Onychomycosis Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Onychomycosis Treatment Forecast
10.4.2 France Market Onychomycosis Treatment Forecast
10.4.3 UK Market Onychomycosis Treatment Forecast
10.4.4 Italy Market Onychomycosis Treatment Forecast
10.4.5 Russia Market Onychomycosis Treatment Forecast
10.5 Middle East & Africa Onychomycosis Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Onychomycosis Treatment Forecast
10.5.2 South Africa Market Onychomycosis Treatment Forecast
10.5.3 Israel Market Onychomycosis Treatment Forecast
10.5.4 Turkey Market Onychomycosis Treatment Forecast
10.6 Global Onychomycosis Treatment Forecast by Type (2026-2031)
10.7 Global Onychomycosis Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Onychomycosis Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Onychomycosis Treatment Product Offered
11.1.3 Johnson & Johnson Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Onychomycosis Treatment Product Offered
11.2.3 GSK Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Onychomycosis Treatment Product Offered
11.3.3 Novartis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Onychomycosis Treatment Product Offered
11.4.3 Pfizer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Bausch Health
11.5.1 Bausch Health Company Information
11.5.2 Bausch Health Onychomycosis Treatment Product Offered
11.5.3 Bausch Health Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bausch Health Main Business Overview
11.5.5 Bausch Health Latest Developments
11.6 Kaken Pharmaceutical
11.6.1 Kaken Pharmaceutical Company Information
11.6.2 Kaken Pharmaceutical Onychomycosis Treatment Product Offered
11.6.3 Kaken Pharmaceutical Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Kaken Pharmaceutical Main Business Overview
11.6.5 Kaken Pharmaceutical Latest Developments
11.7 Galderma
11.7.1 Galderma Company Information
11.7.2 Galderma Onychomycosis Treatment Product Offered
11.7.3 Galderma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Galderma Main Business Overview
11.7.5 Galderma Latest Developments
11.8 Bayer
11.8.1 Bayer Company Information
11.8.2 Bayer Onychomycosis Treatment Product Offered
11.8.3 Bayer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bayer Main Business Overview
11.8.5 Bayer Latest Developments
11.9 Lumenis
11.9.1 Lumenis Company Information
11.9.2 Lumenis Onychomycosis Treatment Product Offered
11.9.3 Lumenis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Lumenis Main Business Overview
11.9.5 Lumenis Latest Developments
11.10 Moberg Pharma
11.10.1 Moberg Pharma Company Information
11.10.2 Moberg Pharma Onychomycosis Treatment Product Offered
11.10.3 Moberg Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Moberg Pharma Main Business Overview
11.10.5 Moberg Pharma Latest Developments
11.11 Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla Onychomycosis Treatment Product Offered
11.11.3 Cipla Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 Biofrontera
11.12.1 Biofrontera Company Information
11.12.2 Biofrontera Onychomycosis Treatment Product Offered
11.12.3 Biofrontera Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biofrontera Main Business Overview
11.12.5 Biofrontera Latest Developments
11.13 Leo Pharma
11.13.1 Leo Pharma Company Information
11.13.2 Leo Pharma Onychomycosis Treatment Product Offered
11.13.3 Leo Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Leo Pharma Main Business Overview
11.13.5 Leo Pharma Latest Developments
11.14 Dr. Reddy's Laboratories
11.14.1 Dr. Reddy's Laboratories Company Information
11.14.2 Dr. Reddy's Laboratories Onychomycosis Treatment Product Offered
11.14.3 Dr. Reddy's Laboratories Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Dr. Reddy's Laboratories Main Business Overview
11.14.5 Dr. Reddy's Laboratories Latest Developments
11.15 Medimetriks Pharmaceuticals
11.15.1 Medimetriks Pharmaceuticals Company Information
11.15.2 Medimetriks Pharmaceuticals Onychomycosis Treatment Product Offered
11.15.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Medimetriks Pharmaceuticals Main Business Overview
11.15.5 Medimetriks Pharmaceuticals Latest Developments
11.16 Xiuzheng Pharmaceutical
11.16.1 Xiuzheng Pharmaceutical Company Information
11.16.2 Xiuzheng Pharmaceutical Onychomycosis Treatment Product Offered
11.16.3 Xiuzheng Pharmaceutical Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Xiuzheng Pharmaceutical Main Business Overview
11.16.5 Xiuzheng Pharmaceutical Latest Developments
11.17 Letai
11.17.1 Letai Company Information
11.17.2 Letai Onychomycosis Treatment Product Offered
11.17.3 Letai Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Letai Main Business Overview
11.17.5 Letai Latest Developments
11.18 Qilu Pharmaceutical
11.18.1 Qilu Pharmaceutical Company Information
11.18.2 Qilu Pharmaceutical Onychomycosis Treatment Product Offered
11.18.3 Qilu Pharmaceutical Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Qilu Pharmaceutical Main Business Overview
11.18.5 Qilu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Onychomycosis Treatment Market Size (2020-2031)
2.1.2 Onychomycosis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Onychomycosis Treatment by Country/Region (2020, 2024 & 2031)
2.2 Onychomycosis Treatment Segment by Type
2.2.1 Oral Medicine
2.2.2 External Medicine
2.3 Onychomycosis Treatment Market Size by Type
2.3.1 Onychomycosis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
2.4 Onychomycosis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Onychomycosis Treatment Market Size by Application
2.5.1 Onychomycosis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
3 ONYCHOMYCOSIS TREATMENT MARKET SIZE BY PLAYER
3.1 Onychomycosis Treatment Market Size Market Share by Player
3.1.1 Global Onychomycosis Treatment Revenue by Player (2020-2025)
3.1.2 Global Onychomycosis Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Onychomycosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS TREATMENT BY REGION
4.1 Onychomycosis Treatment Market Size by Region (2020-2025)
4.2 Global Onychomycosis Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Onychomycosis Treatment Market Size Growth (2020-2025)
4.4 APAC Onychomycosis Treatment Market Size Growth (2020-2025)
4.5 Europe Onychomycosis Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Onychomycosis Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Onychomycosis Treatment Market Size by Country (2020-2025)
5.2 Americas Onychomycosis Treatment Market Size by Type (2020-2025)
5.3 Americas Onychomycosis Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Onychomycosis Treatment Market Size by Region (2020-2025)
6.2 APAC Onychomycosis Treatment Market Size by Type (2020-2025)
6.3 APAC Onychomycosis Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Onychomycosis Treatment Market Size by Country (2020-2025)
7.2 Europe Onychomycosis Treatment Market Size by Type (2020-2025)
7.3 Europe Onychomycosis Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Onychomycosis Treatment by Region (2020-2025)
8.2 Middle East & Africa Onychomycosis Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Onychomycosis Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONYCHOMYCOSIS TREATMENT MARKET FORECAST
10.1 Global Onychomycosis Treatment Forecast by Region (2026-2031)
10.1.1 Global Onychomycosis Treatment Forecast by Region (2026-2031)
10.1.2 Americas Onychomycosis Treatment Forecast
10.1.3 APAC Onychomycosis Treatment Forecast
10.1.4 Europe Onychomycosis Treatment Forecast
10.1.5 Middle East & Africa Onychomycosis Treatment Forecast
10.2 Americas Onychomycosis Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Onychomycosis Treatment Forecast
10.2.2 Canada Market Onychomycosis Treatment Forecast
10.2.3 Mexico Market Onychomycosis Treatment Forecast
10.2.4 Brazil Market Onychomycosis Treatment Forecast
10.3 APAC Onychomycosis Treatment Forecast by Region (2026-2031)
10.3.1 China Onychomycosis Treatment Market Forecast
10.3.2 Japan Market Onychomycosis Treatment Forecast
10.3.3 Korea Market Onychomycosis Treatment Forecast
10.3.4 Southeast Asia Market Onychomycosis Treatment Forecast
10.3.5 India Market Onychomycosis Treatment Forecast
10.3.6 Australia Market Onychomycosis Treatment Forecast
10.4 Europe Onychomycosis Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Onychomycosis Treatment Forecast
10.4.2 France Market Onychomycosis Treatment Forecast
10.4.3 UK Market Onychomycosis Treatment Forecast
10.4.4 Italy Market Onychomycosis Treatment Forecast
10.4.5 Russia Market Onychomycosis Treatment Forecast
10.5 Middle East & Africa Onychomycosis Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Onychomycosis Treatment Forecast
10.5.2 South Africa Market Onychomycosis Treatment Forecast
10.5.3 Israel Market Onychomycosis Treatment Forecast
10.5.4 Turkey Market Onychomycosis Treatment Forecast
10.6 Global Onychomycosis Treatment Forecast by Type (2026-2031)
10.7 Global Onychomycosis Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Onychomycosis Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Onychomycosis Treatment Product Offered
11.1.3 Johnson & Johnson Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Onychomycosis Treatment Product Offered
11.2.3 GSK Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Onychomycosis Treatment Product Offered
11.3.3 Novartis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Onychomycosis Treatment Product Offered
11.4.3 Pfizer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Bausch Health
11.5.1 Bausch Health Company Information
11.5.2 Bausch Health Onychomycosis Treatment Product Offered
11.5.3 Bausch Health Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bausch Health Main Business Overview
11.5.5 Bausch Health Latest Developments
11.6 Kaken Pharmaceutical
11.6.1 Kaken Pharmaceutical Company Information
11.6.2 Kaken Pharmaceutical Onychomycosis Treatment Product Offered
11.6.3 Kaken Pharmaceutical Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Kaken Pharmaceutical Main Business Overview
11.6.5 Kaken Pharmaceutical Latest Developments
11.7 Galderma
11.7.1 Galderma Company Information
11.7.2 Galderma Onychomycosis Treatment Product Offered
11.7.3 Galderma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Galderma Main Business Overview
11.7.5 Galderma Latest Developments
11.8 Bayer
11.8.1 Bayer Company Information
11.8.2 Bayer Onychomycosis Treatment Product Offered
11.8.3 Bayer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bayer Main Business Overview
11.8.5 Bayer Latest Developments
11.9 Lumenis
11.9.1 Lumenis Company Information
11.9.2 Lumenis Onychomycosis Treatment Product Offered
11.9.3 Lumenis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Lumenis Main Business Overview
11.9.5 Lumenis Latest Developments
11.10 Moberg Pharma
11.10.1 Moberg Pharma Company Information
11.10.2 Moberg Pharma Onychomycosis Treatment Product Offered
11.10.3 Moberg Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Moberg Pharma Main Business Overview
11.10.5 Moberg Pharma Latest Developments
11.11 Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla Onychomycosis Treatment Product Offered
11.11.3 Cipla Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 Biofrontera
11.12.1 Biofrontera Company Information
11.12.2 Biofrontera Onychomycosis Treatment Product Offered
11.12.3 Biofrontera Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biofrontera Main Business Overview
11.12.5 Biofrontera Latest Developments
11.13 Leo Pharma
11.13.1 Leo Pharma Company Information
11.13.2 Leo Pharma Onychomycosis Treatment Product Offered
11.13.3 Leo Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Leo Pharma Main Business Overview
11.13.5 Leo Pharma Latest Developments
11.14 Dr. Reddy's Laboratories
11.14.1 Dr. Reddy's Laboratories Company Information
11.14.2 Dr. Reddy's Laboratories Onychomycosis Treatment Product Offered
11.14.3 Dr. Reddy's Laboratories Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Dr. Reddy's Laboratories Main Business Overview
11.14.5 Dr. Reddy's Laboratories Latest Developments
11.15 Medimetriks Pharmaceuticals
11.15.1 Medimetriks Pharmaceuticals Company Information
11.15.2 Medimetriks Pharmaceuticals Onychomycosis Treatment Product Offered
11.15.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Medimetriks Pharmaceuticals Main Business Overview
11.15.5 Medimetriks Pharmaceuticals Latest Developments
11.16 Xiuzheng Pharmaceutical
11.16.1 Xiuzheng Pharmaceutical Company Information
11.16.2 Xiuzheng Pharmaceutical Onychomycosis Treatment Product Offered
11.16.3 Xiuzheng Pharmaceutical Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Xiuzheng Pharmaceutical Main Business Overview
11.16.5 Xiuzheng Pharmaceutical Latest Developments
11.17 Letai
11.17.1 Letai Company Information
11.17.2 Letai Onychomycosis Treatment Product Offered
11.17.3 Letai Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Letai Main Business Overview
11.17.5 Letai Latest Developments
11.18 Qilu Pharmaceutical
11.18.1 Qilu Pharmaceutical Company Information
11.18.2 Qilu Pharmaceutical Onychomycosis Treatment Product Offered
11.18.3 Qilu Pharmaceutical Onychomycosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Qilu Pharmaceutical Main Business Overview
11.18.5 Qilu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Onychomycosis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Onychomycosis Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Medicine
Table 4. Major Players of External Medicine
Table 5. Onychomycosis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Table 8. Onychomycosis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Onychomycosis Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Onychomycosis Treatment Revenue Market Share by Player (2020-2025)
Table 13. Onychomycosis Treatment Key Players Head office and Products Offered
Table 14. Onychomycosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Onychomycosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Onychomycosis Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Onychomycosis Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Onychomycosis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Onychomycosis Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Onychomycosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Onychomycosis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Onychomycosis Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Onychomycosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Onychomycosis Treatment
Table 39. Key Market Challenges & Risks of Onychomycosis Treatment
Table 40. Key Industry Trends of Onychomycosis Treatment
Table 41. Global Onychomycosis Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Onychomycosis Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Onychomycosis Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Onychomycosis Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Johnson & Johnson Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 46. Johnson & Johnson Onychomycosis Treatment Product Offered
Table 47. Johnson & Johnson Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Johnson & Johnson Main Business
Table 49. Johnson & Johnson Latest Developments
Table 50. GSK Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 51. GSK Onychomycosis Treatment Product Offered
Table 52. GSK Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. GSK Main Business
Table 54. GSK Latest Developments
Table 55. Novartis Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 56. Novartis Onychomycosis Treatment Product Offered
Table 57. Novartis Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Pfizer Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 61. Pfizer Onychomycosis Treatment Product Offered
Table 62. Pfizer Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. Bausch Health Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 66. Bausch Health Onychomycosis Treatment Product Offered
Table 67. Bausch Health Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bausch Health Main Business
Table 69. Bausch Health Latest Developments
Table 70. Kaken Pharmaceutical Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 71. Kaken Pharmaceutical Onychomycosis Treatment Product Offered
Table 72. Kaken Pharmaceutical Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Kaken Pharmaceutical Main Business
Table 74. Kaken Pharmaceutical Latest Developments
Table 75. Galderma Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 76. Galderma Onychomycosis Treatment Product Offered
Table 77. Galderma Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Galderma Main Business
Table 79. Galderma Latest Developments
Table 80. Bayer Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 81. Bayer Onychomycosis Treatment Product Offered
Table 82. Bayer Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Bayer Main Business
Table 84. Bayer Latest Developments
Table 85. Lumenis Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 86. Lumenis Onychomycosis Treatment Product Offered
Table 87. Lumenis Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Lumenis Main Business
Table 89. Lumenis Latest Developments
Table 90. Moberg Pharma Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 91. Moberg Pharma Onychomycosis Treatment Product Offered
Table 92. Moberg Pharma Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Moberg Pharma Main Business
Table 94. Moberg Pharma Latest Developments
Table 95. Cipla Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 96. Cipla Onychomycosis Treatment Product Offered
Table 97. Cipla Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cipla Main Business
Table 99. Cipla Latest Developments
Table 100. Biofrontera Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 101. Biofrontera Onychomycosis Treatment Product Offered
Table 102. Biofrontera Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Biofrontera Main Business
Table 104. Biofrontera Latest Developments
Table 105. Leo Pharma Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 106. Leo Pharma Onychomycosis Treatment Product Offered
Table 107. Leo Pharma Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Leo Pharma Main Business
Table 109. Leo Pharma Latest Developments
Table 110. Dr. Reddy's Laboratories Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 111. Dr. Reddy's Laboratories Onychomycosis Treatment Product Offered
Table 112. Dr. Reddy's Laboratories Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Dr. Reddy's Laboratories Main Business
Table 114. Dr. Reddy's Laboratories Latest Developments
Table 115. Medimetriks Pharmaceuticals Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 116. Medimetriks Pharmaceuticals Onychomycosis Treatment Product Offered
Table 117. Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Medimetriks Pharmaceuticals Main Business
Table 119. Medimetriks Pharmaceuticals Latest Developments
Table 120. Xiuzheng Pharmaceutical Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 121. Xiuzheng Pharmaceutical Onychomycosis Treatment Product Offered
Table 122. Xiuzheng Pharmaceutical Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Xiuzheng Pharmaceutical Main Business
Table 124. Xiuzheng Pharmaceutical Latest Developments
Table 125. Letai Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 126. Letai Onychomycosis Treatment Product Offered
Table 127. Letai Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Letai Main Business
Table 129. Letai Latest Developments
Table 130. Qilu Pharmaceutical Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 131. Qilu Pharmaceutical Onychomycosis Treatment Product Offered
Table 132. Qilu Pharmaceutical Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Qilu Pharmaceutical Main Business
Table 134. Qilu Pharmaceutical Latest Developments
Table 1. Onychomycosis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Onychomycosis Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Medicine
Table 4. Major Players of External Medicine
Table 5. Onychomycosis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Table 8. Onychomycosis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Onychomycosis Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Onychomycosis Treatment Revenue Market Share by Player (2020-2025)
Table 13. Onychomycosis Treatment Key Players Head office and Products Offered
Table 14. Onychomycosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Onychomycosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Onychomycosis Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Onychomycosis Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Onychomycosis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Onychomycosis Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Onychomycosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Onychomycosis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Onychomycosis Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Onychomycosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Onychomycosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Onychomycosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Onychomycosis Treatment
Table 39. Key Market Challenges & Risks of Onychomycosis Treatment
Table 40. Key Industry Trends of Onychomycosis Treatment
Table 41. Global Onychomycosis Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Onychomycosis Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Onychomycosis Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Onychomycosis Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Johnson & Johnson Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 46. Johnson & Johnson Onychomycosis Treatment Product Offered
Table 47. Johnson & Johnson Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Johnson & Johnson Main Business
Table 49. Johnson & Johnson Latest Developments
Table 50. GSK Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 51. GSK Onychomycosis Treatment Product Offered
Table 52. GSK Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. GSK Main Business
Table 54. GSK Latest Developments
Table 55. Novartis Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 56. Novartis Onychomycosis Treatment Product Offered
Table 57. Novartis Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Pfizer Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 61. Pfizer Onychomycosis Treatment Product Offered
Table 62. Pfizer Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. Bausch Health Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 66. Bausch Health Onychomycosis Treatment Product Offered
Table 67. Bausch Health Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bausch Health Main Business
Table 69. Bausch Health Latest Developments
Table 70. Kaken Pharmaceutical Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 71. Kaken Pharmaceutical Onychomycosis Treatment Product Offered
Table 72. Kaken Pharmaceutical Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Kaken Pharmaceutical Main Business
Table 74. Kaken Pharmaceutical Latest Developments
Table 75. Galderma Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 76. Galderma Onychomycosis Treatment Product Offered
Table 77. Galderma Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Galderma Main Business
Table 79. Galderma Latest Developments
Table 80. Bayer Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 81. Bayer Onychomycosis Treatment Product Offered
Table 82. Bayer Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Bayer Main Business
Table 84. Bayer Latest Developments
Table 85. Lumenis Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 86. Lumenis Onychomycosis Treatment Product Offered
Table 87. Lumenis Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Lumenis Main Business
Table 89. Lumenis Latest Developments
Table 90. Moberg Pharma Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 91. Moberg Pharma Onychomycosis Treatment Product Offered
Table 92. Moberg Pharma Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Moberg Pharma Main Business
Table 94. Moberg Pharma Latest Developments
Table 95. Cipla Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 96. Cipla Onychomycosis Treatment Product Offered
Table 97. Cipla Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cipla Main Business
Table 99. Cipla Latest Developments
Table 100. Biofrontera Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 101. Biofrontera Onychomycosis Treatment Product Offered
Table 102. Biofrontera Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Biofrontera Main Business
Table 104. Biofrontera Latest Developments
Table 105. Leo Pharma Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 106. Leo Pharma Onychomycosis Treatment Product Offered
Table 107. Leo Pharma Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Leo Pharma Main Business
Table 109. Leo Pharma Latest Developments
Table 110. Dr. Reddy's Laboratories Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 111. Dr. Reddy's Laboratories Onychomycosis Treatment Product Offered
Table 112. Dr. Reddy's Laboratories Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Dr. Reddy's Laboratories Main Business
Table 114. Dr. Reddy's Laboratories Latest Developments
Table 115. Medimetriks Pharmaceuticals Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 116. Medimetriks Pharmaceuticals Onychomycosis Treatment Product Offered
Table 117. Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Medimetriks Pharmaceuticals Main Business
Table 119. Medimetriks Pharmaceuticals Latest Developments
Table 120. Xiuzheng Pharmaceutical Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 121. Xiuzheng Pharmaceutical Onychomycosis Treatment Product Offered
Table 122. Xiuzheng Pharmaceutical Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Xiuzheng Pharmaceutical Main Business
Table 124. Xiuzheng Pharmaceutical Latest Developments
Table 125. Letai Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 126. Letai Onychomycosis Treatment Product Offered
Table 127. Letai Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Letai Main Business
Table 129. Letai Latest Developments
Table 130. Qilu Pharmaceutical Details, Company Type, Onychomycosis Treatment Area Served and Its Competitors
Table 131. Qilu Pharmaceutical Onychomycosis Treatment Product Offered
Table 132. Qilu Pharmaceutical Onychomycosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Qilu Pharmaceutical Main Business
Table 134. Qilu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Onychomycosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Onychomycosis Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Onychomycosis Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Onychomycosis Treatment Sales Market Share by Country/Region (2024)
Figure 8. Onychomycosis Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Onychomycosis Treatment Market Size Market Share by Type in 2024
Figure 10. Onychomycosis Treatment in Hospital Pharmacies
Figure 11. Global Onychomycosis Treatment Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Onychomycosis Treatment in Retail Pharmacies
Figure 13. Global Onychomycosis Treatment Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Onychomycosis Treatment in Online Pharmacies
Figure 15. Global Onychomycosis Treatment Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Onychomycosis Treatment Market Size Market Share by Application in 2024
Figure 17. Global Onychomycosis Treatment Revenue Market Share by Player in 2024
Figure 18. Global Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Onychomycosis Treatment Value Market Share by Country in 2024
Figure 24. United States Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Onychomycosis Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Onychomycosis Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Onychomycosis Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Onychomycosis Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 1. Onychomycosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Onychomycosis Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Onychomycosis Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Onychomycosis Treatment Sales Market Share by Country/Region (2024)
Figure 8. Onychomycosis Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Onychomycosis Treatment Market Size Market Share by Type in 2024
Figure 10. Onychomycosis Treatment in Hospital Pharmacies
Figure 11. Global Onychomycosis Treatment Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Onychomycosis Treatment in Retail Pharmacies
Figure 13. Global Onychomycosis Treatment Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Onychomycosis Treatment in Online Pharmacies
Figure 15. Global Onychomycosis Treatment Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Onychomycosis Treatment Market Size Market Share by Application in 2024
Figure 17. Global Onychomycosis Treatment Revenue Market Share by Player in 2024
Figure 18. Global Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Onychomycosis Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Onychomycosis Treatment Value Market Share by Country in 2024
Figure 24. United States Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Onychomycosis Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Onychomycosis Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Onychomycosis Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Onychomycosis Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Onychomycosis Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Onychomycosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Onychomycosis Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Onychomycosis Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Onychomycosis Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Onychomycosis Treatment Market Size 2026-2031 ($ millions)
More Publications
Global Dermatophytic Onychomycosis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
November 2018
118 pages
